Neuroprotective Natural Products for the Treatment of Parkinson's Disease by Targeting the Autophagy-Lysosome Pathway: A Systematic Review

被引:41
|
作者
Wang, Zi-Ying [1 ,2 ]
Liu, Jing-Yi [1 ,2 ]
Yang, Chuan-Bin [1 ,2 ]
Malampati, Sandeep [1 ,2 ]
Huang, Ying-Yu [1 ,2 ]
Li, Mei-Xiang [1 ,2 ]
Li, Min [1 ]
Song, Ju-Xian [1 ]
机构
[1] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Baptist Univ, Mr & Mrs Ko Chi Ming Ctr Parkinsons Dis Res, Kowloon, Hong Kong, Peoples R China
关键词
Parkinson's disease; autophagy; neuroprotection; natural products; UBIQUITIN-PROTEASOME SYSTEM; ALPHA-SYNUCLEIN; RAT MODEL; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; CELLULAR-MODELS; DOWN-REGULATION; SH-SY5Y CELLS; MTOR; DEGRADATION;
D O I
10.1002/ptr.5834
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The autophagy-lysosome pathway (ALP) is a primary means by which damaged organelles and long-lived proteins are removed from cells and their components recycled. Impairment of the ALP has been found to be linked to the pathogenesis of Parkinson's disease (PD), a chronic neurodegenerative disorder characterized by the accumulation of protein aggregates and loss of dopaminergic neurons in the midbrain. In recent years, some active compounds derived from plants have been found to regulate the ALP and to exert neuroprotective effects in experimental models of PD, raising the possibility that autophagy enhancement may be an effective therapeutic strategy in PD treatment. In this review, we summarize recent findings of natural products that enhance ALP and thereby protect against PD. Research articles were retrieved from PubMed using relevant keywords in combination. Papers related to the topic were identified, and then the reliability of the experiments was assessed in terms of methodology. The results suggest that targeting the ALP with natural products is a promising strategy for PD treatment. However, risk of bias exists in some studies due to the defective methodology. Rigorous experimental design following the guidelines of autophagy assays, molecular target identification and in vivo efficacy evaluation is critical for the development of ALP enhancers for PD treatment in future studies. Copyright (C) 2017 John Wiley & Sons, Ltd.
引用
收藏
页码:1119 / 1127
页数:9
相关论文
共 50 条
  • [21] Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson's Disease
    Rivero-Rios, Pilar
    Madero-Perez, Jesus
    Fernandez, Belen
    Hilfiker, Sabine
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (03) : 238 - 249
  • [22] Cannabinoids' neuroprotective effect as an alternative treatment for Parkinson's disease: A systematic review
    Ortiz, Ana Carolina
    Gavioli, Aline
    Ortiz, Sandra Regina
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 314 - 314
  • [23] CNS Neuropathology in a Mouse Model of Fabry Disease Indicates Alterations in the Autophagy-Lysosome Pathway
    Shacka, John
    Davidson, Kathryn
    Evonuk, Kirsten
    Feng Wenguang
    Jaimes, Edgar
    Warnock, David
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S57 - S57
  • [24] Extracellular Matrix Remodeling Alleviates Memory Deficits in Alzheimer's Disease by Enhancing the Astrocytic Autophagy-Lysosome Pathway
    Yang, Qinghu
    Yan, Chengxiang
    Sun, Yahan
    Xie, Zhen
    Yang, Liang
    Jiang, Ming
    Ni, Junjun
    Chen, Beining
    Xu, Sen
    Yuan, Zhaoyue
    Wu, Yanyan
    Liu, Xia
    Yuan, Zengqiang
    Bai, Zhantao
    ADVANCED SCIENCE, 2024,
  • [25] Lnc-HIBADH-4 Regulates Autophagy-Lysosome Pathway in Amyotrophic Lateral Sclerosis by Targeting Cathepsin D
    Huang, Jingxuan
    Yu, Yujiao
    Pang, Dejiang
    Li, Chunyu
    Wei, Qianqian
    Cheng, Yangfan
    Cui, Yiyuan
    Ou, Ruwei
    Shang, Huifang
    MOLECULAR NEUROBIOLOGY, 2023, 61 (7) : 4768 - 4782
  • [26] The autophagy–lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson's disease
    Fengjuan Jiao
    Lingyan Meng
    Kang Du
    Xuezhi Li
    Neural Regeneration Research, 2025, (01) : 139 - 158
  • [27] Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy
    Liu, Wei Jing
    Shen, Ting Ting
    Chen, Rui Hong
    Wu, Hong-Luan
    Wang, Yan Jin
    Deng, Jian Kun
    Chen, Qiu Hua
    Pan, Qingjun
    Fu, Chang-mei Huang
    Tao, Jing-li
    Liang, Dong
    Liu, Hua-feng
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (33) : 20499 - 20510
  • [28] Buffering of cytosolic calcium plays a neuroprotective role by preserving the autophagy-lysosome pathway during MPP+-induced neuronal death
    Jung, Shinae
    Chung, Yuhyun
    Lee, Yunsoo
    Lee, Yangsin
    Cho, Jin Won
    Shin, Eun-Joo
    Kim, Hyoung-Chun
    Oh, Young J.
    CELL DEATH DISCOVERY, 2019, 5 (1)
  • [29] Buffering of cytosolic calcium plays a neuroprotective role by preserving the autophagy-lysosome pathway during MPP+-induced neuronal death
    Shinae Jung
    Yuhyun Chung
    Yunsoo Lee
    Yangsin Lee
    Jin Won Cho
    Eun-Joo Shin
    Hyoung-Chun Kim
    Young J. Oh
    Cell Death Discovery, 5
  • [30] The roles of the ubiquitin-proteasome and autophagy-lysosome pathways in Huntington's disease and related conditions
    Ravikumar, B
    Sarkar, S
    Berger, Z
    Rubinsztein, DC
    CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (03) : 141 - 148